MDR1 is related to intestinal epithelial injury induced by acetylsalicylic acid

Area of Science:

• Gastroenterology
• Molecular Biology
• Pharmacology

Background:

• Aspirin's cytotoxicity to the intestinal epithelium is a significant clinical issue.
• The precise mechanisms underlying aspirin-induced intestinal cell injury remain largely unknown.

Purpose of the Study:

• To investigate the role of the Multi Drug Resistance (MDR) 1 transporter in aspirin-induced intestinal epithelial cell damage.
• To utilize MDR1 gene-transfected Caco2 cells to elucidate the involvement of MDR1 in aspirin pathogenesis.

Main Methods:

• Caco2 cells were exposed to varying aspirin concentrations.
• Cell injury was quantified using a WST-8 assay after aspirin stimulation.
• The impact of verapamil (an MDR1 inhibitor) and MDR1 gene transfection on aspirin-induced injury was assessed.
• Aspirin efflux was studied using (14)C-labeled aspirin.

Main Results:

• Aspirin-induced cell injury was exacerbated by verapamil treatment.
• MDR1-transfected cells exhibited reduced aspirin-induced injury compared to control cells.
• Aspirin efflux was significantly higher in verapamil-treated cells, indicating MDR1's role in transport.

Conclusions:

• Aspirin efflux is mediated by the MDR1 transporter.
• The MDR1 transporter is implicated in the pathogenesis of aspirin-induced intestinal cell injury.
• Targeting MDR1 may offer a strategy to mitigate aspirin-related gastrointestinal toxicity.